J&J posts weak medical device sales, shares fall
Pharmaceutical sales jumped 7.7% in the quarter to $16.76 billion, but medical technology division sales rose just 2.5% to $8.6 billion.
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
On Oct. 14, 2026, JJSF is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
J&J Snack Foods Corp is a small-cap company with a market capitalization of $1.51B.
A per-ticker accuracy statistic for JJSF is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, JJSF included.
Follow JJSF free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months.
| Metric | JJSF | Rank |
|---|---|---|
| Market Cap | $1.51B | – |
| P/E Ratio | 30.62x | – |
| P/B Ratio | 1.69x | – |
| Dividend Yield | 4.04% | – |
| EPS | $2.98 | – |
| Book Value/Share | $47.75 | – |
| Revenue/Share | $81.62 | – |
| FCF/Share | $4.92 | – |
| Metric | JJSF | Rank |
|---|---|---|
| ROE | 5.5% | – |
| ROA | 3.6% | – |
| ROIC | 5.2% | – |
| Gross Margin | 31.2% | – |
| Operating Margin | 4.0% | – |
| Net Margin | 3.2% | – |
| EBT Margin | 4.0% | – |
| Tax Rate | 19.9% | – |
| Metric | JJSF | Rank |
|---|---|---|
| Current Ratio | 2.34x | – |
| Quick Ratio | 1.47x | – |
| D/E Ratio | 0.52x | – |
| Financial Leverage | 1.52x | – |
| Interest Coverage | 48.0x | – |
| Working Capital | $265M | – |
| Metric | JJSF | Rank |
|---|---|---|
| Operating Cash Flow | $167M | – |
| Free Cash Flow | $92M | – |
| Capital Spending | -$75M | – |
| OCF Growth YoY | 15.1% | – |
| FCF Growth YoY | 38.2% | – |
| FCF/Sales | 6.0% | – |
| CapEx/Sales | 4.9% | – |
| Metric | JJSF | Rank |
|---|---|---|
| Asset Turnover | 1.12x | – |
| Receivables Turnover | 7.2x | – |
| Inventory Turnover | 6.1x | – |
| Fixed Assets Turnover | 4.0x | – |
| Days Sales Outstanding | 50 days | – |
| Days Inventory | 60 days | – |
| Payables Period | 34 days | – |
| Cash Conversion Cycle | 76 days | – |
| Metric | JJSF | Rank |
|---|---|---|
| Total Revenue | $1.52B | – |
| Operating Income | $60M | – |
| Net Income | $49M | – |
| SG&A Expense | $221M | – |
| Cost of Goods Sold | $1.05B | – |
| Metric | JJSF | Rank |
|---|---|---|
| Dividends Per Share | $3.26 | – |
| Payout Ratio | 109.4% | – |
| Shares Outstanding | 19M | – |
| Total Current Assets | $462M | 34.1% of assets |
| Cash & Short-term Investments | $63M | 4.7% of assets |
| Accounts Receivable | $211M | 15.5% of assets |
| Inventory | $171M | 12.6% of assets |
| Total Liabilities | $464M | 34.2% of assets |
| Short-term Debt | $100M | 7.4% of assets |
Companies classified under the same SEC industry code as J&J Snack Foods Corp (Cookies & Crackers): 1 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| JJSF J&J Snack Foods Corp | ▶ | $1.51B |
Pharmaceutical sales jumped 7.7% in the quarter to $16.76 billion, but medical technology division sales rose just 2.5% to $8.6 billion.
NEW YORK, Aug 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions ...
Orthopedics sales generated $9.2 billion last year Company raises 2025 forecast by $300 million Shares drop nearly 2% Oct 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Tuesday it ...
On Oct. 14, 2026, JJSF is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
A per-ticker accuracy statistic for JJSF is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
J&J Snack Foods Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.